» Articles » PMID: 28404911

Flattened Microvessel Independently Predicts Poor Prognosis of Patients with Non-small Cell Lung Cancer

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Apr 14
PMID 28404911
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Angiogenesis plays an essential role in improving tumor progression, whereas, its value in prognosis predicting remains controversial, especially in non-small cell lung cancer (NSCLC). Most recently, microvessel pattern has been raised as a novel prognosis factor. In this study, flattened microvessel, evaluated by tumor microvessel aspect ratio (TMAR), was conducted as a prognostic factor in NSCLC patients. A total of 100 patients with NSCLC were retrospectively reviewed. Microvessel in tumor was visualized by immunochemistry staining and then TMAR was determined. The prognostic role of TMAR was evaluated by univariate and multivariate analysis. Most of intratumor microvessels were flattened with a median TMAR of 3.65 (range, 2.43 - 6.28). Patients were stratified into high TMAR group (TMAR ≥ 3.6) and low TMAR group (TMAR < 3.6). Compared with subpopulation with low TMAR, high TMAR had significantly high risk of cancer-related death (univariate analysis: HR = 5.06, 95% CI: 2.44-10.47, p<0.001; multivariate analysis: HR = 4.53, 95% CI: 1.70-12.06, p=0.002).In conclusion, the results of our study demonstrate that flattened microvessel in tumor tissue is a promising prognosis predictor of NSCLC patients.

Citing Articles

Quantifying the tumour vasculature environment from CD-31 immunohistochemistry images of breast cancer using deep learning based semantic segmentation.

Whitmarsh T, Cope W, Carmona-Bozo J, Manavaki R, Sammut S, Woitek R Breast Cancer Res. 2025; 27(1):17.

PMID: 39905431 PMC: 11796191. DOI: 10.1186/s13058-024-01950-2.


Modified microvessel density based on perfusion distance: a preferable NSCLC prognostic factor.

Tong Y, Yang D, Mi X, Song Y, Xin W, Zhong L Ann Transl Med. 2022; 10(2):43.

PMID: 35282046 PMC: 8848420. DOI: 10.21037/atm-21-6566.


Long Distance From Microvessel to Cancer Cell Predicts Poor Prognosis in Non-Small Cell Lung Cancer Patients.

Ding H, Sun J, Song Y, Xin W, Zhu J, Zhong L Front Oncol. 2021; 11:632352.

PMID: 34178623 PMC: 8226084. DOI: 10.3389/fonc.2021.632352.


Compressed vessels bias red blood cell partitioning at bifurcations in a hematocrit-dependent manner: Implications in tumor blood flow.

Enjalbert R, Hardman D, Kruger T, Bernabeu M Proc Natl Acad Sci U S A. 2021; 118(25).

PMID: 34140409 PMC: 8237689. DOI: 10.1073/pnas.2025236118.


Adjustment of Microvessel Area by Stromal Area to Improve Survival Prediction in Non-Small Cell Lung Cancer.

Fang L, He Y, Liu Y, Ding H, Tong Y, Hu L J Cancer. 2019; 10(15):3397-3406.

PMID: 31293643 PMC: 6603421. DOI: 10.7150/jca.31231.


References
1.
Bremnes R, Camps C, Sirera R . Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer. 2005; 51(2):143-58. DOI: 10.1016/j.lungcan.2005.09.005. View

2.
Duarte I, Bufkin B, Pennington M, Gal A, Cohen C, Kosinski A . Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1998; 115(3):652-8; discussion 658-9. DOI: 10.1016/S0022-5223(98)70331-9. View

3.
Pietras A, Johnsson A, Pahlman S . The HIF-2α-driven pseudo-hypoxic phenotype in tumor aggressiveness, differentiation, and vascularization. Curr Top Microbiol Immunol. 2010; 345:1-20. DOI: 10.1007/82_2010_72. View

4.
Stylianopoulos T, Martin J, Snuderl M, Mpekris F, Jain S, Jain R . Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. Cancer Res. 2013; 73(13):3833-41. PMC: 3702668. DOI: 10.1158/0008-5472.CAN-12-4521. View

5.
Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1(1):27-31. DOI: 10.1038/nm0195-27. View